Startup company Exero Medical announced today that the FDA has granted breakthrough device designation for its wireless system designed for early detection of potentially lethal anastomotic leaks (AL) following gastrointestinal surgery. The FDA scrutinized the company’s pre-clinical data from its animal studies as well as clinical data collected in the first-in-human feasibility trial conducted at […]